|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/40 | |
| A61K 39/395 | |||
| A61P 3/06 |
| (11) | Patento numeris | 3068803 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14810057.1 |
| Europos patento paraiškos padavimo data | 2014-11-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/065149 |
| Data | 2014-11-12 |
| (87) | Numeris | WO 2015/073494 |
| Data | 2015-05-21 |
| (30) | Numeris | Data | Šalis |
| 201361902857 P | 2013-11-12 | US | |
| 201461955337 P | 2014-03-19 | US | |
| 14306222 | 2014-07-31 | EP |
| (72) |
BACCARA-DINET, Marie, FR
BESSAC, Laurence, FR
HANOTIN, Corinne, FR
PORDY, Robert, C., US
SASIELA, William, J., US
REY, Jacques, FR
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
Sanofi Biotechnology, 54 rue La Boétie, 75008 Paris, FR |
| (54) | DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS |
| DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS |